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We present a rare case of Menkes kinky hair syndrome with osseous involvement incidentally identified by a technetium 
Tc 99m dimercaptosuccinic acid (DMSA) scan and confirmed later by a technetium Tc 99m methylene diphosphonate 
bone scan. The patient had global developmental delay, myoclonic seizures from 3.5 months of age, as well as recur-
rent urinary tract infections. Bone involvement was unknown at the time of presentation. A technetium Tc 99m DMSA 
(+3 valency) scan was performed, which was not suggestive of any cortical scars. Incidentally, multiple sites of abnormal 
DMSA uptake were observed in the adjoining ribs. A subsequent technetium Tc 99m methylene diphosphonate whole 
body bone scan showed multiple hot spots in the ribs, bilateral humerus and femurs, suggesting flaring of the ribs, 
metaphyseal spurring, periosteal new bone formation and osteochondrodysplasia.
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Introduction
Menkes kinky hair syndrome1 is also known as 
tricho poliodystrophy or steely hair disease. It is 
a recessive sex-linked syndrome, caused by an 
inborn defect in copper metabolism. It can have 
a familial inheritance pattern as represented in 
our case. The syndrome presents with severe men-
tal retardation, problems in physical development, 
convulsions, and abnormalities of the hair, bones 
and blood vessels. The main cause of all these 
problems is very low levels of copper and cerulo-
plasmin in serum, which indicate the diagnosis 
of Menkes syndrome. The prognosis of such babies 
is poor and they do not survive beyond 3 years of 
life.
Materials and Methods
A patient presented to the hospital with frequent 
episodes of fever. At the time of initial presentation, 
the child was extremely fair. Hair color lightened 
2 months, after birth. The patient’s birth weight was 
2.8 kg. Head control was not attained at 2 months, 
but the child attained a social smile. On examina-
tion, the patient had central hypotonia, dislocata-
ble left and right shoulder joints, low-set ears, jowly 
cheeks, and prominent gums. The abdominal exam-
ination showed the liver to be palpable while the 
spleen was not palpable. The head circumference was 
41.5 cm. The child was born of non-consanguineous 
parentage. There was a family history of death of the 
older sibling (male child) at 7 months of age owing 
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to severe neurodevelopmental delay and seizures 
beginning at 2 months of age. The child was referred 
to the Department of Nuclear Medicine at 2.5 years 
of age with a history of three episodes of culture 
proven urinary tract infection for renal cortical scar 
evaluation.
Results
The chest and skull X-rays did not reveal any obvious 
bony abnormalities (Figures 1 and 2). The electro-
encephalogram was essentially normal. Micturating 
cystourethrogram showed multiple bladder diver-
ticula with significant post void residual urine 
(Figure 3). A technetium Tc 99m dimercaptosuc-
cinic acid (DMSA) (+3 valency) scan was performed 
using 90 MBq of Tc, and DMSA was given as an intra-
venous injection. Two hours later, high-resolution 
static images of the abdomen were acquired using 
a dual head variable gamma camera. Scan findings 
were negative for cortical scars with preserved 
cortical function of both kidneys (Figure 4). 
Inciden tally, multiple sites of abnormal DMSA up-
take were observed in adjoining ribs. A subsequent 
technetium Tc 99m methylene diphosphonate whole 
body bone scan showed multiple hot spots in the ribs, 
bilateral humerus and femurs, suggesting flaring of 
the ribs, metaphyseal spurring, periosteal new bone 
formation and osteochondrodysplasia (Figure 5).
A magnetic resonance cerebral angiogram was 
performed, which showed abnormal tortuosity in the 
intracranial and extracranial blood vessels. A mag-
netic resonance imaging brain scan showed delay 
in myelination with largely unmyelinated corpus 
callosum. Hair microscopy revealed trichorrhexis 
nodosa. Laboratory investigations confirmed the pres-
ence of Menkes kinky hair syndrome with reduced 
serum levels of copper (44.9 μg/dL; reference range, 
65−165 μg/dL).
Discussion
Menkes kinky hair syndrome is associated with 
reduced serum copper and ceruloplasmin levels.2 
Few studies have reported skeletal abnormalities 
in Menkes syndrome, which include metaphyseal 
spurring, periosteal new bone formation, anterior 
flaring of the ribs, and a small skull with excessive 
wormian bones. In addition, most of these bone 
changes resolve by 1 year of age, except for the 
anterior flaring of ribs, mild osteoporosis and re-
tarded bone age.3
Hair findings are the most striking and are invari-
ably the first sign to lead to the diagnosis of Menkes 
syndrome. The hair is light-colored and fragile, and 
Figure 1 Chest X-ray. An initial X-ray shows no evidence 
of any flaring of the ribs.
Figure 2 Skull X-ray. No significant abnormalities and 
no changes in size were observed.
Figure 3 Plain abdominal image shows multiple bladder 
diverticula with significant post void residue.
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fractures easily. Light microscopic studies of hair 
using phase contrast optics shows longitudinal twist-
ing with narrowing and erosions at intervals.4 In 
addition, electron microscopic examination can fur-
ther assist in the identification of Menkes syndrome. 
Various hair shaft abnormalities in Menkes syndrome 
include pili torti (i.e. 180º twisting of the hair shaft), 
which is the most common, followed by trichorrhexis 
nodosa, trichoclasis (i.e. transverse fracture of the 
hair shaft), and trichoptilosis (i.e. longitudinal split-
ting of shaft). The scalp hair is usually normal at 
birth and slowly loses color, and becomes kinky and 
fragile by approximately 3 months of age. Patients 
can also have hypopigmentation of the skin. All of 
these skin and hair changes are caused by tyrosi-
nase deficiency. Hair shafts in this syndrome contain 
nine times the normal amount of free sulfhydryls.5
Cerebral cortical changes can be detected by 
magnetic resonance imaging. Neuroimaging usually 
shows cortical atrophy, enlarged tortuous vessels, 
subdural collections, and progressive and extensive 
degeneration of gray matter with secondary demy-
elination.6 There are no specific reports on the 
associated urogenital abnormalities in Menkes syn-
drome. Bladder diverticula due to muscle hypoto-
nia can lead to bladder outlet obstructions.7 
Recurrent pneumonia is often the most common 
cause of death in these cases.
Management of cases of Menkes syndrome are 
purely supportive. Parenteral injections of copper 
histidine are usually ineffective in arresting pro-
gression and changing the final outcome of the dis-
ease. A few studies8,9 have reported prevention of 
neurologic complications by early administration of 
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Figure 4 Technetium Tc 99m dimercaptosuccinic acid 
(DMSA) scan. High-resolution static images showing no 
focal cold defects in bilateral renal cortices. There were 
incidental findings of abnormal technetium Tc 99m DMSA 
uptake in adjacent ribs. The arrows indicate the abnor-
mal sites of technetium Tc 99m methylene diphospho-
nate uptake in adjacent ribs. Ratio of the percentage 
technetium Tc 99m DMSA uptake in the left to right kidney 
was 53:47.
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Figure 5 Technetium Tc 99m methylene diphosphonate 
whole body bone scan showing multiple hot spots in the 
ribs, bilateral femurs and humerus. Flaring of the ribs, 
metaphyseal spurring, new bone formation, and osteo-
chondrodysplasia were observed. L: left; LAO: left ante-
rior oblique; R: right; RPO: right posterior oblique.
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copper histidine injections. Antiepileptics are used 
supportively in case of seizures.
The prognosis of patients with Menkes syndrome 
is very poor, and death usually occurs by 2−3 years of 
life. One clinical trial measured plasma dopamine, 
norepinephrine, dihydroxyphenylacetic acid, and 
di hydroxyphenylglycol levels in 81 infants at risk.10 
In 12 newborns who met the eligibility criteria, cop-
per-replacement therapy was begun within 22 days 
after birth. Survival and neurodevelopment was 
tracked longitudinally for 1.5−8 years; survival at 
a median follow-up of 4.6 years was 92% compared 
with 13% at a median follow-up of 1.8 years for a 
historical control group of 15 late-diagnosis and 
late-treatment patients. Two of the 12 patients had 
normal neuro development and brain myelination.
Prenatal diagnosis of Menkes syndrome by means 
of DNA mutational analysis may be performed in 
future pregnancies.11 Copper Cu64 incorporation by 
chorionic villus cells or amniotic fluid cells can also 
be attempted for sampling. Molecular methods 
are also available for investigation. Mutations in 
the ATP7A gene (adenosine triphosphatase, Cu2+ 
transporting, alpha polypeptide) cause Menkes 
syndrome.11 ATP7A is a human gene that is located 
in the long arm of the X chromosome. This gene is 
important for regulating copper levels in the body.2 
Copper-dependent metalloenzymes relevant to the 
clinical phenotype include tyrosinase (pigmentation 
of skin and hair), lysyl oxidase (elastin and collagen 
cross-linking), ascorbate oxidase (skeletal devel-
opment), monoamine oxidase (possibly responsible 
for pili torti), superoxide dismutase (free-radical 
detoxification), dopamine beta-hydroxylase (cate-
cholamine production), peptidyl-glycine alpha-
amidating mono-oxygenase (bioactivation of peptide 
hormones), and cytochrome C oxidase (electron 
transport and possibly responsible for hypothermia). 
Mutations produce deletion of a part of this gene 
and are predicted to produce a shortened ATP7A 
protein that is unable to transport copper. Copper 
accumulates in some tissues, such as the small 
intestine and kidneys, while the brain and other 
tissues have unusually low levels. The decreased 
supply of copper can reduce the activity of numer-
ous copper-containing enzymes that are necessary 
for the structure and function of bone, skin, hair, 
blood vessels, and the nervous system.
Abnormal sites of technetium Tc 99m DMSA up-
take were observed in the skeletal system when 
evaluating the patient for cortical scars. The prep-
aration of our technetium Tc 99m DMSA complex 
was stable, because no free pertechnetate was 
visualized in the form of thyroid gland or the stom-
ach. Rondogianni and Koniaris12 reported multiple 
areas of technetium Tc 99m DMSA uptake in color-
ectal carcinoma patients with skeletal metastases. 
They suggested that technetium Tc 99m DMSA could 
be taken into the cells through the damaged cell 
membrane and bind to cytoplasmic proteins and 
mitochondria. Similarly, Lamki and Shearer13 also 
showed technetium Tc 99m DMSA uptake in skele-
tal metastases with prostate carcinoma. The other 
causes of DMSA uptake can be altered capillary per-
meability or slow pooling of the blood. Taking into 
consideration the biologic and physical character-
istics of technetium Tc 99m DMSA, we hypothesize 
that technetium Tc 99m DMSA skeletal uptake is 
linked to an increased osteoblastic response, and 
the different grades of uptake in the lesions are as-
sociated with the difference in activity of the cells.
Our case of Menkes kinky hair syndrome is unique, 
because the child has survived to 3 years of age 
with classical hair, skin and neurologic features ac-
companied by relatively rare osseous and urologic 
changes. Nuclear medicine imaging was useful for 
the whole body evaluation of unsuspected osseous 
involvement; it can be used search for new renal 
cortical scars, percentage individual renal function in 
patients with repeated urinary tract infections and 
also to determine progressive skeletal abnormalities.
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